Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-23-016023
Filing Date
2023-05-01
Accepted
2023-05-01 07:35:32
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A oncr-20221231.htm   iXBRL 10-K/A 1283454
2 EX-31.1 oncr-ex31_1.htm EX-31 13082
3 EX-31.2 oncr-ex31_2.htm EX-31 12358
  Complete submission text file 0000950170-23-016023.txt   1582678

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20221231_pre.xml EX-101.PRE 18469
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20221231.xsd EX-101.SCH 2594
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20221231_lab.xml EX-101.LAB 30073
8 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20221231_htm.xml XML 11093
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39575 | Film No.: 23870031
SIC: 2834 Pharmaceutical Preparations